Artivion (AORT) Enterprise Value Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.47% |
| Dec 31, 2025 | -0.93% |
| Sep 30, 2025 | -2.58% |
| Jun 30, 2025 | 15.77% |
| Mar 31, 2025 | 10.01% |
| Dec 31, 2024 | -9.29% |
| Sep 30, 2024 | -8.61% |
| Jun 30, 2024 | -6.45% |
| Mar 31, 2024 | -4.47% |
| Dec 31, 2023 | -6.89% |
| Sep 30, 2023 | -8.66% |
| Jun 30, 2023 | -13.66% |
| Mar 31, 2023 | -2.36% |
| Dec 31, 2022 | 0.70% |
| Sep 30, 2022 | 28.82% |
| Jun 30, 2022 | 5.38% |
| Mar 31, 2022 | 2.91% |
| Dec 31, 2021 | 0.83% |
| Sep 30, 2021 | -3.48% |
| Jun 30, 2021 | -1.36% |
| Mar 31, 2021 | -4.58% |
| Dec 31, 2020 | -10.03% |
| Sep 30, 2020 | -10.44% |
| Jun 30, 2020 | -28.54% |
| Mar 31, 2020 | -13.96% |
| Dec 31, 2019 | -0.02% |
| Sep 30, 2019 | -3.87% |
| Jun 30, 2019 | -1.79% |
| Mar 31, 2019 | -1.33% |
| Dec 31, 2018 | 0.35% |
| Sep 30, 2018 | -14.43% |
| Jun 30, 2018 | -16.39% |
| Mar 31, 2018 | -25.11% |
| Dec 31, 2017 | -25.04% |
| Sep 30, 2017 | -46.64% |
| Jun 30, 2017 | -65.33% |
| Mar 31, 2017 | -22.66% |
| Dec 31, 2016 | -21.10% |
| Sep 30, 2016 | -15.79% |
| Jun 30, 2016 | -13.68% |
| Mar 31, 2016 | -3.96% |
| Dec 31, 2015 | 1.20% |
| Sep 30, 2015 | -4.88% |
| Jun 30, 2015 | 0.11% |
| Dec 31, 2014 | -2.61% |